Recruiting Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients NCT07176312 Conditions Digestive System Diseases, Digestive System Neoplasms, First Line Therapy, +14 more Locations Charité CVK — Berlin, Germany Vivantes Klinikum im Friedrichshain — Berlin, Germany Klinikum Bielefeld — Bielefeld, Germany Städtisches Klinikum Dresden — Dresden, Germany View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients NCT06928376 Conditions Acute Myeloid Leukemia, First Line Therapy, Hematologic Diseases, +6 more Locations Chinese PLA General Hospital — Beijing, Beijing Municipality, China View Trial Details
Recruiting Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC NCT07050043 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more Locations Hospital Sultanah Bahiyah — Alor Star, Kedah, Malaysia View Trial Details
Not Yet Recruiting Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial NCT07610499 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
